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 Abstract 
Staphylococcus epidermidis GOI1153754-03-14 is able to colonize orthopedic implants and to cause 
septic non-unions, as validated in a recent in vivo study (Lovati et al., 2016). To the mechanisms leading 
to the biofilm formation on metallic implants, we carried out the phenotypic and genotypic 
characterization of the clinical isolate S. epidermidis GOI1153754-03-14.  
The antimicrobial susceptibility and minimum inhibitory concentration (MIC) of the strain were 
evaluated through the Vitek2 System (Biomerieux), as well as its ability to form biofilm in vitro through 
a spectrophotometric assay (Stepanovich et al., 2000). 
The genomic DNA was extracted by Bacterial Genomic DNA Isolation Kit (Norgen Biotek Corp.). 
Libraries were prepared with the ThruPLEX DNA-seq (Rubicon Genomics) and then sequenced on the 
Illumina MiSeq platform through the MiSeq Reagent Kit v3 (600-cycles) to produce 300 bp paired-end 
reads (Illumina Inc.). Reads were quality-trimmed and gene annotated thanks to the RAST software 
(Aziz et al., 2008). 
The antimicrobial susceptibility along with the MIC values are reported in Table 1. The outputs resulted 
in 51 contigs (Average = 50,720.6 Mb) with 396X fold average coverage. The total genome is 2,586,753 
bp long with a GC content of 31.84% and an N50 value of 7 bp. The whole genome is composed by 
2,467 protein-encoding genes and 64 RNAs (55 tRNAs and 9 rRNAs). The entire genome sequence has 
been deposited in the European Nucleotide Archive (ENA) under the accession no. FWCG01000000 
(Bottagisio et al., 2017).  
The genotypic and phenotypic characterization of the S. epidermidis GOI1153754-03-14 will enable a 
better comprehension of the mechanisms involved in the biofilm formation on orthopedic implants, 
paving the way for innovative preventative and therapeutic strategies. Moreover, the sequence of 
this clinical strain is mandatory to develop dedicated proteomics analysis in order to highlight 
functional mechanism of biofilm formation. 
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Table 1: Antimicrobial susceptibility and MIC values 
Antibiotic Antimicrobial susceptibility MIC 
Benzylpenicillin Resistant ≥ 0.5 
Oxacillin Resistant ≥ 4 
Levofloxacin Resistant  4 
Rifampicin Resistant  ≥ 4 
Gentamicin Susceptible  ≤ 0.5 
Erythromycin Susceptible ≤ 0.25 
Clindamycin Susceptible ≤ 0.12 
Linezolid Susceptible  1 
Daptomycin Susceptible 0.25 
Teicoplanin Susceptible 4 
Vancomycin Susceptible ≤ 0.5 
Tetracycline Susceptible ≤ 1 
Tigecycline Susceptible ≤ 0.12 
Fusidic acid Susceptible ≤ 0.5 
Trimethoprim/ Sulfamethoxazole Susceptible ≤ 10 
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